A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2011
10/26/2011	CN102224924A Sea cucumber saponin-containing composition and its application in foods and drugs
10/26/2011	CN101972434B Traditional Chinese medicine for treating diabetes mellitus
10/26/2011	CN101966221B Application of prickly pear in preparation of medicaments or health-care products
10/26/2011	CN101926899B Health-care medicament for hyperlipemia and preparation method thereof
10/26/2011	CN101919882B Application of red yeast rice to preparing abdominal aneurvsm medicine
10/26/2011	CN101857646B Method for extracting high-purity beta-glucan and whole oat flour from oat bran
10/26/2011	CN101698028B Fat-reducing and weight-losing composite and preparation method thereof
10/26/2011	CN101664543B Hemokinin-iron oral liquid
10/26/2011	CN101585863B Method for preparing yamogenin
10/26/2011	CN101579436B Medicinal composition for treating adiposity
10/26/2011	CN101559148B Pharmaceutical composition for treating diabetes and/or hyperlipemia and preparation method thereof
10/26/2011	CN101524422B Health products with hypolipemic function, preparation method and usage thereof
10/26/2011	CN101513450B Pharmaceutical composition for preventing and treating chronic complicating diseases of diabetes
10/26/2011	CN101485834B Chinese medicine for treating diabetes
10/26/2011	CN101426492B Inhibitor of increase in postprandial blood insulin level
10/26/2011	CN101204216B Coffee partner containing octacosanol and manufacture method thereof
10/26/2011	CN101048166B Abnormal protein removing composition
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011	US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044025 Urocortin proteins and uses thereof
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	CA2581225C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/25/2011	CA2486380C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/25/2011	CA2399865C Novel scavenger receptor
10/25/2011	CA2366277C Grb7 family proteins and the insulin receptor for screening new medications
10/20/2011	WO2011130729A2 Methods for treating metabolic disorders using fgf
10/20/2011	WO2011130618A2 Compositions and methods for producing glycosylated human pdx-1 protein and methods of use therefore
10/20/2011	WO2011130611A2 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
10/20/2011	WO2011130459A1 Novel glucokinase activators and methods of using same
10/20/2011	WO2011130342A1 FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
10/20/2011	WO2011128413A1 Process for the production of polymorph form i of agomelatine
10/20/2011	WO2011128395A1 N- substituted 3-amino 4 - ( pyrrolidine - 1 - carbonyl) pyrrolidine and its derivatives for use in the treatment of metabolic disorders
10/20/2011	WO2011128394A1 3-substituted 5-(pyrrolidine-1-carbonyl) pyrrolidine and its derivatives for use in the treatment of metabolic disorders
10/20/2011	WO2011128374A1 Insulin-sirna conjugates
10/20/2011	WO2011128316A1 Azacyclic spiroderivatives as hsl inhibitors
10/20/2011	WO2011128251A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	WO2011127643A1 Pyridone derivatives
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011075210A3 Small molecules that covalently modify transthyretin
10/20/2011	WO2011038110A3 Methods of treating metabolic disease
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257268 Reduction of Sterols and Other Compounds from Oils
10/20/2011	US20110257264 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
10/20/2011	US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011	US20110257242 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission
10/20/2011	US20110257240 Stabilized statin formulations
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011	US20110257230 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257227 Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257221 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257213 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/20/2011	US20110257212 New azacyclic derivatives
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257205 Xanthine derivatives as selective hm74a agonists
10/20/2011	US20110257202 Therapeutic Compositions and Methods for Treating Chronic Kidney Disease Associated with a Metabolic Imbalance
10/20/2011	US20110257194 Substituted oxindol derivatives and medicaments containing the same
10/20/2011	US20110257179 Novel thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257174 Chromenone analogs as sirtuin modulators
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110257163 Gamma secretase modulators
10/20/2011	US20110257161 Novel diaza-bicyclononyl-phenyl derivatives and their medical use
10/20/2011	US20110257151 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	US20110257149 Formulation for oral transmucosal administration of lipid-lowering drugs
10/20/2011	US20110257140 Biomarkers of Mineralocorticoid Receptor Activation
10/20/2011	US20110257132 Charged phospholipid compositions and methods for their use
10/20/2011	US20110257130 Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
10/20/2011	US20110257127 A2b adenosine receptor antagonists
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257119 Microcirculation improvement and/or treatment
10/20/2011	US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257097 Pharmaceutical compositions of somatotrophic hormones
10/20/2011	US20110257092 Glucagon/glp-1 receptor co-agonists
10/20/2011	US20110257091 Insulin analogs
10/20/2011	US20110257089 Liquid high-fat protein composition
10/20/2011	US20110257088 Low-Concentration Nutritional Composition
10/20/2011	US20110257087 Protein Hydrolysate Compositions Having Enhanced CCK Releasing Activity
10/20/2011	US20110257086 Methods for synthesis and uses of inhibitors of ghrelin o-acyltransferase as potential therapeutic agents for obesity and diabetes
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110257084 Exendin derivative linked biotin, method for the preparation thereof and pharmaceutical composition comprising the same
10/20/2011	US20110257076 Amide based insulin prodrugs
10/20/2011	US20110257074 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256220 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof
10/20/2011	US20110256199 Melt extrusion encapsulation of flavors and other encapsulates in a carrier containing spices and herbs
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256159 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256152 Methods Of Treating And Preventing Glucose Toxicity
10/20/2011	US20110256151 Antibodies to human il-1beta

1 ... 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 ... 1298